Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4905)
All Articles published online
|
Jan 14, 2010 (publication date) through Apr 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Roth LS, Chande N, Ponich T, Roth ML, Gregor J. Predictors of disease severity in ulcerative colitis patients from Southwestern Ontario. World J Gastroenterol 2010; 16(2): 232-236 [PMID: 20066743 DOI: 10.3748/wjg.v16.i2.232] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i2/232.htm |
| Number | Citing Articles |
| 1 |
Elizabeth A. Spencer. Choosing the Right Therapy at the Right Time for Pediatric Inflammatory Bowel Disease. Gastroenterology Clinics of North America 2023; 52(3): 517 doi: 10.1016/j.gtc.2023.05.006
|
| 2 |
Anastasios Koulaouzidis, Sarah Douglas, Marie A. Rogers, Ian D. Arnott, John N. Plevris. Fecal calprotectin: A selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy. Scandinavian Journal of Gastroenterology 2011; 46(5): 561 doi: 10.3109/00365521.2011.551835
|
| 3 |
Maria K. Magnusson, Hans Strid, Stefan Isaksson, Magnus Simrén, Lena Öhman. The Mucosal Antibacterial Response Profile and Fecal Microbiota Composition Are Linked to the Disease Course in Patients with Newly Diagnosed Ulcerative Colitis. Inflammatory Bowel Diseases 2017; 23(6): 956 doi: 10.1097/MIB.0000000000001130
|
| 4 |
Rocío Sedano Muñoz, Rodrigo Quera Pino, Patricio Ibáñez Lazo, Carolina Figueroa Corona, Lilian Flores Pérez. Aminosalicylates, thiopurines and methotrexate in inflammatory bowel disease: Is it possible to discontinue the treatment?. Gastroenterología y Hepatología (English Edition) 2019; 42(5): 339 doi: 10.1016/j.gastre.2019.01.016
|
| 5 |
Jacques Cosnes, Harry Sokol. Crohn's Disease and Ulcerative Colitis. 2017; : 653 doi: 10.1007/978-3-319-33703-6_61
|
| 6 |
Nishani Jayasooriya, Samantha Baillie, Jonathan Blackwell, Alex Bottle, Irene Petersen, Hanna Creese, Sonia Saxena, Richard C. Pollok. Systematic review with meta‐analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2023; 57(6): 635 doi: 10.1111/apt.17370
|
| 7 |
Paula Calderón, Paulina Núñez, Pilar Nos, Rodrigo Quera. Personalised therapy in inflammatory bowel disease. Gastroenterología y Hepatología (English Edition) 2024; 47(7): 763 doi: 10.1016/j.gastre.2024.04.057
|
| 8 |
Jacques Cosnes, Corinne Gower–Rousseau, Philippe Seksik, Antoine Cortot. Epidemiology and Natural History of Inflammatory Bowel Diseases. Gastroenterology 2011; 140(6): 1785 doi: 10.1053/j.gastro.2011.01.055
|
| 9 |
Yavuz Ozdemir, Ravi P. Kiran, Hasan H. Erem, Erman Aytac, Emre Gorgun, David Magnuson, Feza H. Remzi. Functional Outcomes and Complications after Restorative Proctocolectomy and Ileal Pouch Anal Anastomosis in the Pediatric Population. Journal of the American College of Surgeons 2014; 218(3): 328 doi: 10.1016/j.jamcollsurg.2013.11.019
|
| 10 |
Walter Reinisch, Andrew R. Reinink, Peter D.R. Higgins. Factors Associated With Poor Outcomes in Adults With Newly Diagnosed Ulcerative Colitis. Clinical Gastroenterology and Hepatology 2015; 13(4): 635 doi: 10.1016/j.cgh.2014.03.037
|
| 11 |
Erman Aytac, David W. Dietz, Jean Ashburn, Feza H. Remzi. Long-term Outcomes After Continent Ileostomy Creation in Patients With Crohn’s Disease. Diseases of the Colon & Rectum 2017; 60(5): 508 doi: 10.1097/DCR.0000000000000815
|
| 12 |
Jacques Cosnes, Harry Sokol, Philippe Seksik. Crohn's Disease and Ulcerative Colitis. 2012; : 713 doi: 10.1007/978-1-4614-0998-4_56
|
| 13 |
Manasi Agrawal, Elizabeth A. Spencer, Jean-Frederic Colombel, Ryan C. Ungaro. Approach to the Management of Recently Diagnosed Inflammatory Bowel Disease Patients: A User’s Guide for Adult and Pediatric Gastroenterologists. Gastroenterology 2021; 161(1): 47 doi: 10.1053/j.gastro.2021.04.063
|
| 14 |
Paula Calderón, Paulina Núñez, Pilar Nos, Rodrigo Quera. Terapia personalizada en la enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 2024; 47(7): 763 doi: 10.1016/j.gastrohep.2023.12.006
|
| 15 |
Rachel Archer, Paul Tappenden, Shijie Ren, Marrissa Martyn-St James, Rebecca Harvey, Hasan Basarir, John Stevens, Christopher Carroll, Anna Cantrell, Alan Lobo, Sami Hoque. Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model. Health Technology Assessment 2016; 20(39): 1 doi: 10.3310/hta20390
|
| 16 |
Jinhua Lu, Jun Zhou, Lu Wang, Chun Zhong, Xu Chen, Bo Jia. Efficacy and safety evaluation of acupoint embedding for patients with ulcerative colitis. Medicine 2020; 99(34): e21812 doi: 10.1097/MD.0000000000021812
|
| 17 |
Claudia Ott, Angela Takses, Florian Obermeier, Elisabeth Schnoy, Bernd Salzberger, Martina Müller. How fast up the ladder? Factors associated with immunosuppressive or anti-TNF therapies in IBD patients at early stages: results from a population-based cohort. International Journal of Colorectal Disease 2014; 29(11): 1329 doi: 10.1007/s00384-014-2002-z
|
| 18 |
Marina Aloi, Giulia DʼArcangelo, Matteo Bramuzzo, Marco Gasparetto, Massimo Martinelli, Patrizia Alvisi, Maria Teresa Illiceto, Simona Valenti, Manuela Distante, Salvatore Pellegrino, Simona Gatti, Serena Arrigo, Fortunata Civitelli, Stefano Martelossi. Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis. Inflammatory Bowel Diseases 2016; 22(7): 1647 doi: 10.1097/MIB.0000000000000828
|
| 19 |
Charumathi Raghu Subramanian, George Triadafilopoulos. Care of inflammatory bowel disease patients in remission. Gastroenterology Report 2016; : gow032 doi: 10.1093/gastro/gow032
|
| 20 |
Rocío Sedano Muñoz, Rodrigo Quera Pino, Patricio Ibáñez Lazo, Carolina Figueroa Corona, Lilian Flores Pérez. Aminosalicilatos, tiopurínicos y metotrexato en la enfermedad inflamatoria intestinal, ¿es posible suspender el tratamiento?. Gastroenterología y Hepatología 2019; 42(5): 339 doi: 10.1016/j.gastrohep.2019.01.013
|
| 21 |
Carmen Muñoz Villafranca, Maria Teresa Bravo Rodríguez, Jone Ortiz de Zárate, Paz Arreba González, Iñigo García Kamiruaga, Juan Ignacio Heras Martín, Pilar Cabezudo Gil, Víctor Orive Cura. Clinical outcome after discontinuation of infliximab in patients with ulcerative colitis in deep remission. Gastroenterología y Hepatología (English Edition) 2016; 39(7): 442 doi: 10.1016/j.gastre.2016.06.012
|
| 22 |
Carmen Muñoz Villafranca, Maria Teresa Bravo Rodríguez, Jone Ortiz de Zárate, Paz Arreba González, Iñigo García Kamiruaga, Juan Ignacio Heras Martín, Pilar Cabezudo Gil, Víctor Orive Cura. Evolución clínica tras la suspensión de infliximab en pacientes con colitis ulcerosa en remisión profunda. Gastroenterología y Hepatología 2016; 39(7): 442 doi: 10.1016/j.gastrohep.2015.11.011
|
| 23 |
Ji Yeon Kim, Dong Il Park, Dong Soo Han, Kyu-Chan Huh, Chang Kyun Lee, Jeong Eun Shin, Jae Hak Kim, You Sun Kim, Yunho Jung, Sung-Ae Jung, Hyun Joo Song, Hyun Joo Jang, Young-Ho Kim, Sung No Hong. Comparing the clinical outcomes of young-onset and adult-onset ulcerative colitis: a multi-center Korean Association for the Study for Intestinal Diseases study. The Korean Journal of Internal Medicine 2017; 32(1): 69 doi: 10.3904/kjim.2014.262
|
| 24 |
Elizabeth A. Spencer, Manasi Agrawal, Tine Jess. Prognostication in inflammatory bowel disease. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.1025375
|